Log in
Enquire now
Medeor Therapeutics

Medeor Therapeutics

Medeor Therapeutics is a biotechnology company developing personalized cellular immunotherapies to improve health outcomes of patients receiving organ transplants.

OverviewStructured DataIssuesContributors
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Medeor Therapeutics

https://www.youtube.com/watch?v=nRwTcaK7KTs

October 24, 2017

Medeor Therapeutics Expands Executive Team

Medeor Therapeutics

https://www.prnewswire.com/news-releases/medeor-therapeutics-expands-executive-team-300624062.html

Web

Medeor Therapeutics Receives FDA Clearance of IND Application and Special Protocol Assessment for Pivotal Clinical Study of MDR-101

Medeor Therapeutics

https://www.globenewswire.com/news-release/2017/04/28/974311/0/en/Medeor-Therapeutics-Receives-FDA-Clearance-of-IND-Application-and-Special-Protocol-Assessment-for-Pivotal-Clinical-Study-of-MDR-101.html

Web

Medeor Therapeutics scores $57 mln Series B

Iris Dorbian

https://www.pehub.com/2017/11/medeor-therapeutics-scores-57-mln-series-b/

Web

References

Find more companies like Medeor Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.